Immunicum
Immunicum: Promising Preclinical Data at Major Congress (Redeye)

2020-09-17 15:19
Redeye views the data presented at ESMO as supportive for the future development of ilixadencel in combination with checkpoint inhibitors. It is encouraging for what we consider would likely be the most lucrative future path for Immunicum.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

Mendus - I dag

{point.key}

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex

Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor

Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor

Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror

Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -